Xiao, Yi
Xiang, Ling
Jiang, Yahui
Tang, Yunhao
Gu, Haitao
Wang, Yaxu
Peng, Linglong http://orcid.org/0000-0001-5774-3110
Funding for this research was provided by:
Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission (CSTB2022NSCQ-MSX1005, cstc2021jcyj-msxmX0153, cstc2021jcyj-msxmX0112)
Article History
Received: 30 September 2023
Accepted: 27 February 2024
First Online: 5 March 2024
Declarations
:
: The PLCO Cancer Screening Trial was conducted following the Declaration of Helsinki and approved by the institutional review boards at the National Cancer Institute and 10 participating study centers. Informed consent was obtained from all participants prior to enrollment. PLCO Cancer Screening Trial obtained informed consent from all individual participants included in the study during the recruitment process. The NCI has provided approval for our present study (Project ID: PLCO-1292).
: Not applicable.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.